Skip to main content

Table 2 Percentage of the surveyed physicians answering in line with the ARIA México 2014 recommendations/suggestions on the 1 st part of the treatment of allergic rhinitis: antihistamines (ARIA Guideline, Block 3)

From: How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps

Clinical questions Block 3: Treatment of allergic rhinitis without asthma

ARIA México 2014#

% of physicians with the ‘correct’ answer##

Allergists

ENTs

Pulm

Peds

GPs

12. Should oral H1-antiH be used for the treatment of AR?

R: 2ndge-neration

93

93

81

90

83

13. Should new-generation oral H1-antiH versus old-generation oral H1-antiH be used for the treatment of AR?

R: 2ndge-neration

96

96

94

92

89

14. Should oral H1-antiH be used in preschool children with other allergic diseases for the prevention of wheezing or asthma?

Sug: no

69

46***

68

60

41***

15. Should intranasal H1-antiH be used for treatment of AR?

Sug: yes

65

54

37***

45

76

16. Should newer oral H1-antiH versus intranasal H1-antiH be used for treatment of AR?

S:new, oral anti-H1s

77

69

74***

59

57***

17. Should oral leukotriene receptor antagonists be used for treatment of AR?

Sug: yes

66

70

82*

70

62

18. Should oral leukotriene receptor antagonists versus oral H1-antiH be used for treatment of AR?.

S:new, oral anti-H1s

85

81

59***

48***

64***

  1. H1-antiH = H1 antihistamines, # ARIA México recommendation (R) or suggestion (S).
  2. ## = % of physicians per specialty answering as suggested/recommended by ARIA México 2014 [6].
  3. * = p < 0.05 and *** = p < 0.001 statistically significant difference with the opinion of the allergists.